|
| ID |
DDInter996 |
| Drug Type |
small molecule |
| Molecular Formula |
C27H36N2O5 |
| Molecular Weight |
468.594
|
| Description |
Ivabradine is a HCN channel blocker used to reduce the risk of hospitalization for worsening heart failure in adult patients and for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy in pediatric patients.
|
| ATC Classification |
C01EB17
C07FX05
C07FX06
|
| IUPAC Name |
3-[3-({[(7S)-3,4-Dimethoxybicyclo[4.2.0]Octa-1,3,5-Trien-7-Yl]Methyl}(Methyl)Amino)Propyl]-7,8-Dimethoxy-2,3,4,5-Tetrahydro-1H-3 |
| InChI |
Inchi=1S/C27H36N2O5/C1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30/H12-14,16,21H,6-11,15,17H2,1-5H3/T21-/M1/S1 |
| InChI Key |
ACRHBAYQBXXRTO-OAQYLSRUSA-N |
| Canonical SMILES |
COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|